Statement of Changes in Beneficial Ownership (4)
January 04 2021 - 5:23PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Thomas Isiah III |
2. Issuer Name and Ticker or Trading Symbol
One World Pharma, Inc.
[
OWPC
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) CEO and Vice Chairman |
(Last)
(First)
(Middle)
3471 WEST OQUENDO ROAD, SUITE 301 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
12/31/2020 |
(Street)
LAS VEGAS, NV 89118
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to buy) | $0.55 | 12/31/2020 | | D | | | 5500000 | (1) | 6/3/2030 | Common Stock | 5500000 | $0 | 0 | D | |
Stock Option (Right to buy) | $0.13 | 1/1/2021 | | A | | 5500000 | | (2) | 12/31/2030 | Common Stock | 5500000 | $0 | 5500000 | D | |
Explanation of Responses: |
(1) | The option vested as to 1,500,000 shares immediately upon issuance (June 3, 2020), as to 1,000,000 shares 120 days following the issuance date of the option (the "Second Vesting Date"), and as to the remaining 3,000,000 shares, quarterly over the three years following the Second Vesting Date. |
(2) | The option vests as to 2,275,000 shares immediately, and as to the remaining 2,750,000 shares, in 11 installments of 250,000 shares each, on the 1st day of each of the next 11 calendar quarters, beginning April 1, 2021. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Thomas Isiah III 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS, NV 89118 | X |
| CEO and Vice Chairman |
|
Signatures
|
/s/ Isiah L. Thomas III | | 1/4/2021 |
**Signature of Reporting Person | Date |
One World Products (QB) (USOTC:OWPC)
Historical Stock Chart
From Aug 2024 to Sep 2024
One World Products (QB) (USOTC:OWPC)
Historical Stock Chart
From Sep 2023 to Sep 2024